Pay for Performance and Control of BP in People With CKD
Pay for Performance and Control of BP in People With CKD
Following the introduction of renal indicators into P4P, a significant improvement in BP was seen in a large primary care population of patients with CKD 3–5.
The cost of the BP reduction in terms of increased prescribing was modest and is likely to be cost-effective, given the potential health gains achievable through the achieved improvements in BP control.
Conclusion
Following the introduction of renal indicators into P4P, a significant improvement in BP was seen in a large primary care population of patients with CKD 3–5.
The cost of the BP reduction in terms of increased prescribing was modest and is likely to be cost-effective, given the potential health gains achievable through the achieved improvements in BP control.
Source...